Skip to main content
. Author manuscript; available in PMC: 2012 Apr 4.
Published in final edited form as: Arch Intern Med. 2011 Jan 10;171(1):46–53. doi: 10.1001/archinternmed.2010.451

Table 3.

Thirty-Day Multiple Point Prevalence Abstinence Rates for the Designated Follow-up and All Preceding Intervals.

Group
Between-Group Comparisonsa
Follow-Up Bl EI EI+P All BI vs EI BI vs EI+P EI vs EI+P
3 mo
 No. b 62 68 128
 ITT,% 9.1 10.4 19.0 <.001 .42 <.001 <.001
 Responders, % 11.6 13.6 25.9 <.001 .31 <.001 <.001
6 mo
 No. b 45 48 84
 ITT,% 6.6 7.4 12.4 <.001 .59 <.001 .002
 Responders, % 9.4 11.0 19.8 <.001 .41 <.001 <.001
12 mo
 No. b 31 31 64
 ITT,% 4.6 4.8 9.5 <.001 .87 <.001 .004
 Responders, % 7.3 7.9 17.2 <.001 .75 <.001 <.001
18 mo
 No. b 24 29 52
 ITT,% 3.5 4.5 7.7 .002 .39 .001 .02
 Responders, % 6.2 8.2 15.0 <.001 .30 <.001 .005

Abbreviations: BI, basic Internet; EI, enhanced Internet; EI!P, enhanced Internet and telephone counseling; ellipses, not applicable; ITT, intent to treat.

a

P values are listed for omnibus test and pairwise comparisons.

b

Number of individuals per group who achieved 30-day point prevalence abstinence for the designated follow-up and all preceding intervals.